Background: Efforts to prevent injection drug use (IDU) are increasingly focused on the role that people who inject drugs (PWID) play in the assistance with injection initiation. We studied the association between recent (ie, past 6 months) injection-related HIV risk behaviors and injection initiation assistance into IDU among PWID in the US-Mexico border region.
INTRODUCTION
San Diego, California, the eighth largest city in the United States, 1 is located at the western edge of the United States-Mexico border and is home to a large mobile population of people who inject drugs (PWID). Tijuana, Baja California, is the fifth largest Mexican city and 2 is contiguous with San Diego, California, and the most recent estimate from the Mexican National Center for HIV/AIDS Prevention and Control suggests that approximately 10,000 PWID reside there. 3 Factors, such as injection practices, influencing the risk of acquiring and transmitting blood-borne infections among PWID in both cities have been identified. One recent study found that more than half of PWID in the San DiegoTijuana region had recently engaged in HIV injection risk behaviors, and that current coinjection of methamphetamine and heroin was significantly associated with injection risk behaviors compared with coinjection of heroin or methamphetamine by itself (ie, goofballs). 4 Furthermore, this binational region has been identified as a high-risk area where the transmission of blood-borne infections, namely HIV and hepatitis C virus (HCV), clusters synergistically with a range of other injection-related harms, 5, 6 cultivating a syndemic of excess disease burden among PWID in this region. 7 This is due largely to the fact that the San Diego-Tijuana border region is a key node along a transcontinental drug trafficking route stretching from the Andean region in South America to the United States and Canada. 8 Although HIV prevalence among PWID seems to be similar in San Diego (7%) 9 and Tijuana (4%), 10 HCV prevalence substantially differs, ranging from 27% to 51% in San Diego, 11 and approximately 96% in Tijuana. 6 Of note, there is also evidence of current bidirectional cross-border HIV transmissions among risk groups, including PWID, 12 along with cross-border population mixing of PWID. In a study undertaken among PWID in Tijuana, we found that injection initiation assistance was independently associated with reporting living in the United States for 1-5 years, compared with no history of migration to the United States. 13 We also previously reported on an association between recent distributive syringe sharing (ie, passing on a used syringe or needle to another PWID) among San Diego-based PWID and engaging in crossborder injection drug use (IDU) in Mexico. 14 Although the social norms protective against IDU are comparatively weaker in the United States, 15 Tijuana's close proximity to San Diego, along with the migration of PWID from other parts of Mexico and deportees returning from the United States, has contributed to the expansion of the PWID population. 14 In the case of PWID in San Diego, the city's high-volume border crossing and status as a transit point for drug trafficking also increases the availability of drugs commonly used by injection. 5, 14 As such, research seeking to characterize and respond to injectionrelated blood-borne disease transmission in this setting is increasingly considering the San Diego-Tijuana international metropolitan region as a single "risk environment." 16 Within this risk environment, the border heightens the syndemic of injection-related health and social harms among PWID, and complicates efforts to effectively respond to these harms.
Given the intersecting epidemics of IDU, injectionrelated social harms, and blood-borne infectious disease concentrated among PWID in this region, we approach our understanding of factors contributing to injection initiation from a syndemics framework. 7 A syndemic is defined as a set of linked health problems involving 2 or more afflictions, interacting synergistically, which contribute to excess burden of disease in a population. 7 In this context, the incidence of IDU initiation is increasingly understood as a socially communicable phenomenon that has its roots in the exposure to and sharing of injection practices by established PWID with injection-naive individuals. 17 Given the high prevalence of injection-related risk behaviors among PWID in the San Diego-Tijuana region, determining their linkages with reports of injection initiation assistance provision may therefore provide unique insight into the syndemic of disease transmission risk and IDU initiation. Advancing our understanding of how injection-related disease transmission behaviors and IDU initiation intersect within populations of PWID is of critical public health relevance given data demonstrating the risk of blood-borne infections are higher within the first year of an individual's injection initiation event. 18 We therefore aimed to study the association between recent (ie, past 6 months) injectionrelated risk behaviors and injection initiation assistance among a binational sample of PWID.
METHODS

Sample and Procedures
This analysis was undertaken as part of the Preventing Injection by Modifying Existing Responses (PRIMER) study, a longitudinal multisite study seeking to investigate social, structural, and biomedical factors associated with IDU initiation through pooled analyses of data from existing cohort study mechanisms. The methods and rationale for this study have previously been described in full. 19 The present analysis included data from 2 cohorts participating in the PRIMER study. Specifically, beginning in 2011, PWID in Tijuana, Baja California, Mexico, and San Diego, California, United States, were enrolled in 2 complementary prospective cohort studies [Proyecto El Cuete IV (ECIV) and Study of Tuberculosis, AIDS, and Hepatitis C Risk (STAHR II), respectively] that included interviewer-administered surveys at baseline and semiannually for 2 years. A full description of both cohort methodologies is available elsewhere. 20 Recruitment for both cohorts involved direct street-and venue-based outreach, and inclusion criteria were as follows: being 18 years or older, having injected drugs in the past month, speaking English or Spanish, currently living in Tijuana or San Diego, respectively, with no plans to move, and not currently participating in an intervention study. Data were collected during face-to-face interviews using computerassisted personal interview technology. The ECIV, STAHR II, and PRIMER study protocols were approved by the Human Research Protections Program of the University of California, San Diego. The ECIV study protocol was also approved by the ethics board at El Colegio de la Frontera Norte (Tijuana, Mexico).
Measures
As part of the PRIMER study, survey items soliciting data on participants' history of assistance with injection initiation were introduced in visit 7 of ECIV and the 24-month follow-up visit in STAHR II (ie, beginning in September 2014). The outcome was defined as reporting having assisted someone to initiate IDU in the past 6 months. Items for both survey questionnaires also included a range of items related to sociodemographic characteristics, housing, drug use, and other behaviors. The primary independent variable of interest was defined as reporting one or more of 4 distinct injection risk behaviors: (1) distributive syringe sharing, (2) receptive syringe sharing (ie, using a syringe that someone else has used first), (3) sharing a dose in a syringe (known as "backloading"), and (4) sharing injection paraphernalia (ie, water, cooker, and cotton). These 4 risk behaviors have previously shown to be associated with increased blood-borne disease transmission risk. 21, 22 Additional covariables of interest considered as potential confounders and included in the current study were as follows: age, sex (woman and man), housing status (defined as living in a house or apartment owned by participants, their parents, friends, or partner vs. other), and injection frequency. All behavioral questions referred to the 6-month period before interview.
Statistical Analyses
The present analysis was undertaken using data from the PRIMER baseline (ie, ECIV visit 7; STAHR II 24-month follow-up visit). Descriptive statistics were calculated using data for each cohort separately first and then in combination. Cross-tabulations and the Fisher exact test evaluated univariate associations between reporting recent injection initiation assistance and potential risk factors among the combined sample. Injection risk behavior variables were highly correlated (ranging from r = 0.83 between distributive and backloading to r = 0.91 between distributive and receptive syringe use); therefore, we calculated the sum of injection risk behaviors on a scale of 0-4, corresponding to the number of risk behaviors that participants reported engaging in. This approach is adapted from previous work investigating the impact of multiple psychiatric comorbidities on suicide risk. 23 This summative approach further reflects the cumulative syndemic burden of injection risk behaviors among PWID on injection initiation events. 24 We tested for sex differences by injection risk behaviors (Table 1 , Supplemental Digital Contet, http://links.lww.com/QAI/B217). Multivariable logistic regression models were used to assess the association between the sum of recent injection risk behaviors and recent injection initiation provision. We used a protocol whereby participant cohort, age, and sex were included a priori while other factors were included based on statistical significance in univariate analysis at a threshold of P , 0.05. We restricted the logistic regression analyses to PWID reporting having injected at least once in the past 6 months. We also performed independent multivariable models by sex ( 
RESULTS
A total sample of 892 participants enrolled in the San Diego (n = 358, 40.1%) and Tijuana (n = 534, 59.9%) cohorts completed the PRIMER baseline. 
The subsequent analyses were performed with the participants that reported IDU in the past 6 months (n = 690). Table 2 presents univariate associations between reporting having assisted someone into IDU in the past 6 months and variables assessing sociodemographic factors and injection-related risk behaviors. A significantly larger proportion of men compared with women reported recently assisting others with their injection initiation (6.7% vs. 2.9%, P = 0.049). There were no significant differences with respect to the level of stable housing (4.0% vs. 7.3%, P = 0.060) or median age (41.7, IQR = 36.6-50.6 vs. 42.6, IQR = 35.0-50.2, P = 0.968) between those participants who did and did not report providing injection initiation assistance.
With respect to drug-related behaviors, there was no significant difference in the proportion of those who reported recently assisting with injection initiation with respect to recent injection frequency (ie, less than daily 5.2% vs. daily = 5.4%, P . 0.999), levels of distributive syringe sharing (6.2% vs. 4.5%, P = 0.399), engagement in receptive syringe sharing (6.8% vs. 3.9%; P = 0.127), or backloading (6.6% vs. 3.9%; P = 0.129). By contrast, those who reported sharing injecting paraphernalia also reported significantly the higher levels of injection initiation assistance compared with those who did not (6.8% vs. 2.8%; P = 0.023). The median sum of injection risk behaviors of participants reporting assisting others into injection was 3 (IQR = 2-4) compared with 2 (IQR = 0-4) among those who did not assist others into injection initiation (P = 0.057).
Finally, in multivariable logistic regression (Table 3) , for each additional cumulative (sum) injection risk behavior, participants were 1.3 times more likely to provide injection initiation assistance (adjusted odds ratio per risk behavior increase = 1.3; 95% confidence intervals = 1.0 to 1.6). This means compared to PWID with no injection risk behaviors, those reporting all 4 injection risk behaviors at baseline were 5.2 times more likely to have initiated others into IDU in the past 6 months. We detected no significant differences in the odds of providing injection initiation assistance by cohort, age, and sex.
DISCUSSION
Overall, 4.6% of a binational sample of PWID in the San Diego-Tijuana border region reported assisting with injection initiation in the past 6 months; and 60% reported recently engaging in at least 1 injection-related HIV risk behavior. Furthermore, in a multivariable model, each additional injection risk behavior reported by participants was associated with an approximately 30% increase in the odds of injection initiation assistance, demonstrating that greater syndemic burden of cumulative injection risk behaviors is a significant risk factor for injection initiation. These findings have implications for the prevention of syndemic of injection-driven disease transmission. This is, to the best of our knowledge, the first study to identify an association between engaging in HIV injection risk behaviors and injection initiation assistance among established PWID. Of concern, more than half of participants who reported providing injection initiation assistance also reported distributive syringe sharing (58.0%). This implies that recent IDU initiates in our setting are at a high risk of HIV and HCV acquisition: first, the risk of being initiated with a used syringe has been shown to dramatically increase the risk of blood-borne infection; 25 second, these results imply the possibility of the dissemination of high-risk injection practices to recently initiated PWID, who may then disseminate these practices to others, thereby establishing high-risk injecting behavioral norms. We note, however, the potential for bidirectional disease transmission may exist among established PWID and potential initiate dyads through sexual transmission, as previous studies in Tijuana have established that HIV-seropositivity among PWID is associated with syphilis, 26 implying that HIV transmission may be spread through both injection risk behaviors and unprotected sex. Regardless of the route of transmission risk, these may suggest that initiator-initiate relationships may act as key nodes in the expansion of epidemics of HIV and HCV through multiple transmission routes. Unlike others, 27 we did not find a significant association between gender and reports of providing injection initiation assistance or engaging in injection risk behaviors. However, it is possible that in the context of the San DiegoTijuana border, a region that experiences intense stigma around providing injection initiation assistance, 28 as well as stigma surrounding HIV risk behaviors among women involved in the region's large sex work scene, 29 such behaviors may be underreported among women. However, we do recognize the need to further identify the mechanisms associated with sex dynamics, substance use, and HIV. 30 These results have specific implications for efforts to prevent syndemic of IDU and blood-borne disease transmission. Findings suggest the need for interventions to address the pooling of "classic" injection risk behaviors -ie, those that increase the risk of disease acquisition or transmission-and the sharing of IDU practices, which seems to be a necessary but not sufficient risk factor for the incidence of IDU initiation among vulnerable drugusing populations. In line with others, we note that interventions are needed not only to prevent injection initiation, 31 but that such interventions should also incorporate harm reduction approaches for established PWID (ie, sufficiently resourced syringe exchanges to reduce syringe injection risk practices), as well as recent IDU initiates to educate them regarding safer injection techniques to prevent vein damage and transmission of blood-borne infections. One such example is an intervention pioneered by Small et al, in which "hit doctors" (ie, PWID who provide injection assistance to others for a fee) are trained to perform outreach in streetbased drug scenes to provide safer injecting education for vulnerable PWID. 32 Adaptation of this model should be explored in other settings for PWID at risk of assisting 33 These findings stress the unique risks related to IDU experienced by PWID on both sides of the San DiegoTijuana border. The risks are influenced by the geopolitical separation imposed by the border, the region's high volume deportation and migration flows, 34 and the border region's status as a key drug trafficking hub. 35 As such, we analyzed the United States-Mexico border region using data from comparable cohorts of PWID across the entirety of this international metropolitan region. The lack of a significant difference in the odds of recent injection initiation assistance provision among participants across both cohorts suggests initial validation of this approach. In addition, we did not find a significant difference in recent injection initiation by cohort, which is in line with findings by Mehta et al 12 suggesting that HIV clusters straddle the San Diego-Tijuana region.
This study has several limitations. First, given its crosssectional nature, we cannot assume a causal relationship between injection risk behaviors and the provision of injection initiation assistance. Second, as a result of the construction of a composite variable, we may have reduced our capacity to detect the individual contributions of specific risk behaviors on injection initiation risk. However, given that the risk behaviors were highly correlated, the composite variable provides a more grounded analysis than addressing each risk individually. Third, we were not able to determine whether PWID who engaged in injection risk behaviors did so with IDU initiates. Qualitative research is therefore needed to explore injection risk behavior engagement and transmission among established PWID and recent IDU initiates. Fourth, survey data did not allow for further exploration of the context of injection initiation assistance. However, previous qualitative research has found that injection initiation is both solicited by injection-naive persons and offered by established PWID. 28, 36 Fifth, this analysis is based on self-reports and as such, we cannot assume unbiased reporting. In particular, it is probable that participants underreported injection initiation assistance provision given that it is a highly stigmatized behavior 37 associated with shame and guilt. 38 However, both of our field teams have years of experience working with the San Diego-Tijuana PWID population. We expect this may have increased response frequencies among PWID for survey items related to this sensitive topic. Finally, future research should focus on the type of relationships between PWID who assist others with drug injection and injection-naive people.
In sum, PWID's reports of recently assisting with injection initiation increased as the number of reported HIV-associated injecting risk behaviors increased. Given the lack of health services tailored for PWID in this setting, preventive interventions should therefore include injection education for both recent initiates and initiators to reduce the dissemination of high-risk HIV injection behaviors.
